Get In Touch

Assisted reproductive technology (ART) comprises various medical procedures used to help in conception. Drugs play a major role in these procedures. The use of different classes of drugs in assisted reproduction has gained traction in recent years, due to a rise in prevalence of infertility. These drugs help at various phases of treatment in order to help with hormone regulation, triggered timed ovulation, and the prevention of ovarian hyperstimulation syndrome.

A decline in fertility rates is anticipated to drive the global assisted reproductive technology drugs treatment market. According to a report published by the United Nations (UN), the total fertility rate was 2.5 children per woman globally in 2015. However, high procedural cost of assisted reproductive techniques and non-supportive government regulations for certain infertility treatment options are anticipated to hamper the market during the forecast period. 

Based on drug, the global assisted reproductive technology drugs treatment market can be classified into GnRH agonists, GnRH antagonists, gonadotropins, human chorionic gonadotropins, and others. The GnRH agonints segment is projected to account for a significant share of the market in the near future, as these drugs effectively work on endometriosis and help control the menstrual cycle. In terms of distribution channel, the global assisted reproductive technology drugs treatment market can be categorized into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is expected to constitute a considerable share of the market during the forecast period, because the various processes of assisted reproduction are usually carried out in hospitals as patients need constant monitoring and checkups. Therefore, patients prefer to visit hospitals and buy drugs from hospital pharmacies for their convenience. 

In terms of region, the global assisted reproductive technology drugs treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global assisted reproductive technology drugs treatment market during the forecast period due to an increase in the number of infertility cases. According to the Centers for Disease Control and Prevention, in 2015, approximately 15% of couples in the U.S. were involuntarily infertile and depended on ART treatment to have their own child. Additionally, according to a report released by the Centers for Disease Control and Prevention, in 2016, the fertility rate in U.S. dropped to the lowest level ever recorded. This means that fewer babies are being born to women of childbearing age. Europe dominates the global assisted reproductive technology drugs treatment market due to factors such as issues of involuntary childlessness, favorable reimbursement policies, and regulation od ART treatment. Rise in tourism for surrogacy and low cost of the ART procedure in Asia Pacific compared to that in developed countries are driving the assisted reproductive technology drugs treatment market in Asia Pacific. A decline in fertility rates, rise in demand for fertility treatment, and investment by key players in the expansion of fertility clinics are some factors that are likely to propel the assisted reproductive technology drugs treatment market in Middle East & Africa during the forecast period.

Major players operating in the global assisted reproductive technology drugs treatment market include AbbVie Inc., Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Sun Pharma, and Abbott.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Assisted Reproductive Technology Drugs Treatment Market